Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 CAD | +6.80% | -2.48% | -53.13% |
14/05 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.13% | 1.75Cr | |
+69.84% | 6.29TCr | |
-1.03% | 4.14TCr | |
+45.66% | 4.04TCr | |
-10.72% | 2.76TCr | |
+14.28% | 2.65TCr | |
-21.96% | 1.89TCr | |
+4.54% | 1.27TCr | |
+23.99% | 1.23TCr | |
+28.41% | 1.21TCr |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- Aptose Biosciences : Up 4.9% After Hours as Second-Quarter Loss Narrows on Lower Expenses